Luke Green

Lecturer

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Luke Green is a Lecturer at the University of Sheffield, United Kingdom. His research primarily focuses on the interaction of viruses, particularly SARS-CoV-2, with host cells, and the mechanisms underlying bacterial infections, exemplified by his recent work on Pseudomonas aeruginosa and Neisseria meningitidis. He has contributed to significant findings regarding the clinical severity of COVID-19 variants and the transmission dynamics of SARS-CoV-2 in hospital settings.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (32)

C. Patrick McClure

UNITED KINGDOM

Luke Green

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Tetraspanin CD9-derived peptides inhibit Pseudomonas aeruginosa corneal infection and aid in wound healing of corneal epithelial cells

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

Variable disruption of epithelial monolayers by Neisseria meningitidis carriage isolates of the hypervirulent MenW cc11 and MenY cc23 lineages

CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway

The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2

Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves.

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collaborators (32)

C. Patrick McClure

Agnes Oszlanczi

Matthew Dorman

James R Edgar

James Price

Matthew Bashton

Thomas Whalley

Timofey Skvortsov

A ΜΑΝΤΖΟΥΡΑΤΟΥ

Erika Molteni

Eric Kerfoot

Christopher Bayliss

Yann Bourgeois

Mark Graham

Eleri Sarah Wyn Wilson-Davies

Claire Turner

Damien Tully

Dr Benjamin Lindsey

Dennis Wang

Dami Aderonke Collier

Barbara Ciani

Elias Allara

Martin Patrick McHugh

Deborah Lavin

Neil Oldfield

Marit J. van Gils

Mark Collins

David Partridge

Brendan Payne

Salma Gayed

Temi Lampejo

John Henderson

Make your next move.